Clinical Trial

A Study to Assess the Pharmacokinetics, Safety and Tolerability of Single-dose Adagrasib (BMS-986503) in Healthy Participants of Japanese Descent

Name: A Study to Assess the Pharmacokinetics, Safety and Tolerability of Single-dose Adagrasib (BMS-986503) in Healthy Participants of Japanese Descent — clinical trial record (NCT07723118)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The aim of this study is to assess the pharmacokinetics, safety and tolerability of single-dose Adagrasib (BMS-986503) in healthy participants of Japanese descent

Trial Details

NCT Number	NCT07723118
Lead Sponsor	Mirati Therapeutics Inc.
Conditions	Healthy Participants
Enrollment	10 participants
Start Date	2026-08-05
Primary Completion	2026-09-08 (estimated)
Study Completion	2026-09-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-23